Amit Etkin

Chief Executive Officer at ALTO NEUROSCIENCE, INC.

Net worth: 23 M $ as of 2026-07-30

50 year

24 connections

Consumer Services

Finance

Health Technology

Profile

Amit Etkin is the founder of Alto Neuroscience, Inc., founded in 2019, serving as Chairman & Chief Executive Officer since 2026.
Former jobs include Professor at Stanford University School of Medicine.
Education history includes a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Massachusetts Institute of Technology.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ALTO NEUROSCIENCE, INC. 2.15%	2026-05-13	833,949 ( 2.15% )	23 M $	2026-07-30

Amit Etkin active positions

Companies	Position	Start
ALTO NEUROSCIENCE, INC.	Chief Executive Officer	2019-03-24

All active positions of Amit Etkin

Former positions of Amit Etkin

Companies	Position	End
Stanford University School of Medicine Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

See the detail of Amit Etkin's experience

Training of Amit Etkin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Amit Etkin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
Stanford University School of Medicine Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alto Neuroscience, Inc. Alto Neuroscience, Inc. BiotechnologyHealth Technology Engages in psychiatric drug development	Health Technology